Bladder Cancer
Innovative strategies to refine delivery of neoadjuvant therapy for muscle-invasive bladder cancer
Bladder cancer is the fifth most common cancer in Canada, yet it remains under-recognized and underfunded. Because of this, treatments have lagged behind, especially for muscle-invasive bladder cancer...
Read More